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Background: Aging and physical inactivity are associated with declines in some cognitive domains and
cerebrovascular function, as well as an elevated risk of cerebrovascular disease and other morbidities. With the
increase in the number of sedentary older Canadians, promoting healthy brain aging is becoming an increasingly
important population health issue. Emerging research suggests that higher levels of physical fitness at any age are
associated with better cognitive functioning and this may be mediated, at least in part, by improvements in
cerebrovascular reserve. We are currently conducting a study to determine: if a structured 6-month aerobic exercise
program is associated with improvements or maintenance of both cerebrovascular function and cognitive abilities
in older individuals; and, the extent to which any changes seen persist 6 months after the completion of the
structured exercise program.
Methods/design: Two hundred and fifty men and women aged 55–80 years are being enrolled into an 18-month
combined quasi-experimental and prospective cohort study. Participants are eligible for enrollment into the study if
they are inactive (i.e., not participating in regular physical activity), non-smokers, have a body mass index <35.0 kg/
m2, are free of significant cognitive impairment (defined as a Montreal Cognitive Assessment score of 24 or more),
and do not have clinically significant cardiovascular, cerebrovascular disease, or chronic obstructive pulmonary
airway disease. Repeated measurements are done during three sequential six-month phases: 1) pre-intervention;
2) aerobic exercise intervention; and 3) post-intervention. These outcomes include: cardiorespiratory fitness, resting
cerebral blood flow, cerebrovascular reserve, and cognitive function.
Discussion: This is the first study to our knowledge that will examine contemporaneously the effect of an exercise
intervention on both cerebrovascular reserve and cognition in an older population. This study will further our
understanding of whether cerebrovascular mechanisms might explain how exercise promotes healthy brain aging.
In addition our study will address the potential of increasing physical activity to prevent age-associated cognitive
decline.
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Aging is associated with declines in certain cognitive
domains and lower levels of physical activity [1,2]. The
Public Health Agency of Canada [2] and World Health
Organization [3] report that adults between 65 and 74 years
of age are the most sedentary portion of the population.
An estimated 60% of older adults lead sedentary lifestyles
and do not engage in enough physical activity to achieve
favorable health benefits [4]. Physical inactivity is a
recognized modifiable risk factor of cerebrovascular
disease and the cognitive decline seen in older adults [5,6].
With the projected doubling of the number of older
Canadians over the next 25 years [7], it is anticipated that
the personal and societal burden of age-associated
conditions like cerebrovascular disease and dementia (e.g.,
Alzheimer’s disease, AD) will increase substantially [8].
Post-maturational aging is associated with reduced
abilities in a number of cognitive processes, including
attention, learning and memory, and executive control
[9]. These age-related changes, while detectable, are gen-
erally considered part of the aging process and usually
do not interfere with the ability to live independently.
Dementia, an acquired decline in multiple cognitive
areas causing a significant impairment in social or occu-
pational functioning , occurs in approximately 8% in the
older population, with AD and vascular dementia (VaD)
either alone or in combination the most common causes
[10,11]. As both aging and vascular disease are risk
factors for both AD and VaD, age-associated declines in
cerebrovascular function might contribute to the devel-
opment of these disorders [11-13].
With normal aging there is an approximately 5%
decrease per decade in resting cerebral blood flow (CBF)
[14]. Although the brain represents 2.0 to 2.3% of an
adult’s total body weight, in percentage terms it accounts
for ten times more of the body’s total resting energy
consumption [15,16]. Since cerebral tissue does not pro-
duce or store sources of energy, its high metabolic need
requires constant and adequate blood supply. Age-
related hypoperfusion may be associated with sufficient
reductions in the delivery of oxygen and nutrients and
inadequate removal of metabolic by-products to produce
impaired cognitive function and slowly progressive cellu-
lar injury [17]. Neurons, glial and vascular cells are
linked together in neurovascular units where neuronal
and glial signals control local CBF [17-19]. With aging,
neurovascular coupling is disrupted, which could result
in the metabolic requirements of the brain tissue not
being matched by CBF [15,18]. Decreases in CBF have
been associated with a number of age-related neuro-
degenerative changes including a loss of neuropil (i.e.,
synaptically dense regions of the nervous system mainly
composed of unmyelinated axons, dendrites and glial
processes) [20].There is consistent evidence that regular exercise
promotes brain health and is associated with a lower risk
for age-related cognitive decline and dementia [21],
however the underlying mechanisms have not been well
defined [22]. Neuroimaging studies of older adults indi-
cate that higher levels of cardiovascular fitness are
associated with larger volumes of specific brain regions
including the hippocampus, an important region for
learning and memory [23,24]. This effect may be attrib-
utable, in part, to neurogenesis [25] possibly mediated
by increases in vascularization, elevated levels of neuro-
trophins and growth factors, and/or improved neuronal
survival in the aging brain [26].
Previous studies have focused primarily on neuronal
processes that may explain why physical activity
promotes healthy brain aging while cerebrovascular
mechanisms that might underlie improved cognitive
function are relatively poorly understood. Pharmaco-
logical manipulation of cerebral blood flow can modify
performance on a variety of cognitive tasks in both
animal models and humans (for review see [15,27]).
Cerebrovascular networks are thought to have a high de-
gree of plasticity (i.e., they are changeable or modifiable)
[27]. Exercise appears to stimulate the growth of new ca-
pillaries from preexisting vessels in the brain and im-
prove resting CBF [27,28]. We recently demonstrated
that increased levels of physical fitness were associated
with greater cerebrovascular reserve (i.e., the ability of
cerebral arteries to dilate in response to a stimulus) and
improved cognitive function [12]. These data suggest
that the link between physical fitness and cognition may
be mediated, at least in part, by improvements in cere-
brovascular function.
We are conducting a quasi-experimental prospective
cohort study with two primary aims: 1) to determine the
effect of a six-month aerobic exercise intervention on
physical fitness, resting CBF, cerebrovascular reserve,
and cognitive function in 250 sedentary men and women
between the ages of 55 and 80 years; and, 2) to deter-
mine the extent to which the changes in cerebrovascular
and cognitive function persist six months following the
completion of the exercise intervention. We hypothesize
the improvement in cognitive function derived from
regular aerobic exercise is at least partially mediated by
enhanced cerebrovascular reserve. Further, we hypothesize
that these beneficial changes will persist in participants
who remain physically active as compared to those who
revert to a sedentary lifestyle. The purpose of this manu-
script is to describe the study design and research meth-
odologies in detail.
Methods
The Brain in Motion (BIM) study is an 18-month com-
bined quasi-experimental and prospective cohort study
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phase; 2) aerobic exercise intervention phase; and 3) post-
intervention (Figure 1).Participant recruitment
The target population for enrollment is sedentary men and
women aged 55–80 years. Participants are being recruited
through media, poster and newspaper advertisements.
Potential participants must provide informed written
consent prior to enrollment into the study. Participants are
also invited to provide separate written consent for genetic
testing (see section on Blood Sampling and Biomarker
Assessments). The study protocol was approved by the
University of Calgary Conjoint Health Research Ethics
Board.Inclusion/exclusion criteria
During an initial phone interview, interested participants
are assessed for their eligibility based on pre-determined
inclusion and exclusion criteria (Table 1). Potential parti-
cipants who successfully complete an initial telephone-
based evaluation are then scheduled for a 60-minute
on-site assessment of eligibility (Table 1).Pre-intervention Phase Test 1A  
Pre-intervention Phase Test 1B  
Intervention Phase Test 2A  
Intervention Phase Test 2B  
Post-intervention Phase Test 3  
Figure 1 Flow chart of the phases of the BIM study.Study design
The BIM study design and timeline is outlined in
Figure 1. A second baseline measure allows an estimate
of practice effects on the cognitive test performance and
an estimate of the consistency of our other various
measures. Additionally, this second assessment ensures
feasibility of the testing in the selected study population
and that participants will comply with follow-up testing
prior to the exercise intervention.
Pre-intervention baseline phase test 1A (month 0)
The baseline assessment during the pre-intervention
phase is conducted during four separate on-site appoint-
ments during which the following are done: 1) fasting
blood work; 2) incremental treadmill test to assess max-
imal aerobic capacity (VO2max); 3) assessment of cerebro-
vascular function; and 4) assessment of cognitive function,
mood and sleep (Table 2). In addition, participants are
required to fill out a Dietary History Questionnaire based
on their intake over the previous 12 months [30]. Details
of these evaluations are given later.
Pre-intervention baseline phase test 1B (month 6)
Six months following enrollment into the study, and im-
mediately prior to the exercise intervention phase,Baseline Determination 
6 Month Duration 
No lifestyle changes 
Exercise Continued 
3 days/week Exercise 
3 Month Term 
Exercise Intervention 
3 days/week Exercise 




6 Month Term 
Table 1 Inclusion criteria – participant must fulfill all criteria to be admitted to the study
Assessment phase Criteria
Telephone interview Participant engages in less than 30 minutes of moderate exercise four days per week or 20 continuous minutes
of vigorous exercise two days per week
Participant has a body mass index (BMI) of less than 35 kg/m2
Participant is able to walk independently outside and up and down at least 20 stairs
Participant has not been diagnosed with an active cardiovascular/cerebrovascular disease or obstructive
airway disease that would preclude their ability to safely exercise
Participant has been a non-smoker for at least 12 months
Participant has not had major surgery or trauma in the last six months
Participant is free of debilitating neurological disorders (e.g., Multiple Sclerosis and AD)
Participant has written permission from their attending physician to participate in the study
On-site assessment Montreal Cognitive Assessment (MoCA) score≥ 24 [29]
History (i.e., cardiovascular, respiratory, hepatic, endocrine, neurological, endocrine, and musculoskeletal health)
and physical examination by a study physician to assess safety/appropriateness for exercise. Current medications
(i.e., prescribed, over-the-counter, and complementary agents), allergies, and/or history of any substance abuse issues noted.
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ing Pre-Intervention Baseline Phase Test 1A (see Table 2
for details). At an additional visit, the Lifetime Physical
Activity Questionnaire [31] is administered by study
personnel.
Exercise intervention phase (months 6–12)
Participants then take part in the supervised six-month
aerobic training program that is held three days per week at
the Fitness Centre in the Faculty of Kinesiology at the
University of Calgary. Each exercise session includes a five-
minute warm up, aerobic exercise, a five-minute cool down,Table 2 Table of testing and questionnaires at each
phase
Time (months)
0 6 9 12 18
Phase
Tests 1A 1B 2A 2B 3
Blood work ✓ ✓ ✓ ✓ ✓
Genetics ✓
Maximal aerobic capacity ✓ ✓ ✓ ✓ ✓
Cerebrovascular function ✓ ✓ ✓ ✓ ✓
Cognitive function ✓ ✓ ✓ ✓
Questionnaires
Mood ✓ ✓ ✓ ✓ ✓
Sleep ✓ ✓ ✓ ✓ ✓
Lifetime physical activity ✓
Past year physical activity ✓
Past six month physical activity ✓
Diet History ✓ ✓
Social Support ✓and stretching. Exercise prescriptions follow American
College of Sports Medicine guidelines [32]. As participants
progress through the exercise intervention, the duration of
aerobic exercise (in addition to warm up and cool down)
increases from 20 to 40 minutes. Exercise intensity is
determined based on individual VO2max. The intensity
builds from 30–45% until 60–70% maximum heart rate re-
serve (HRR) is achieved. Participants wear a PolarW heart
rate monitor at each session to ensure compliance to their
target heart rate zones. Heart rate data are collected and
stored during each exercise session and are then exported
offline following the exercise session to analyze heart rates
during the exercise session (PolarW Team2 system). Par-
ticipants are considered compliant if they attend at least
85% of the total exercise sessions. If an exercise session is
missed, participants are strongly encouraged to “make-up”
the session independently and record the unsupervised
exercise session in a personal workout logbook. In
addition to “make-up” exercise sessions, participants are
also required to record any additional independent un-
supervised exercise sessions.
Intervention phase test 2A (month 9)
Midway (3 months) through the exercise program, parti-
cipants undergo repeat testing (same evaluations done
during Phase Test 1A/1B (see Table 2 for details)) to
assess for changes in parameters over time. Based on
their results, exercise prescriptions for participants may
be adjusted. In addition, sleep and mood are assessed by
self-report questionnaires.
Exercise intervention phase test 2B (month 12)
Repeat testing is again done at the end of the 6-month
intervention (see Table 2 for details). The Dietary
History Questionnaire [28] and a Past Year Physical
Tyndall et al. BMC Geriatrics 2013, 13:21 Page 5 of 10
http://www.biomedcentral.com/1471-2318/13/21Activity Questionnaire [33] (details given later) are self-
administered questionnaires completed at this time point.
Post-intervention phase test 3 (month 18)
Six-months following the completion of the exercise
intervention, participants are re-evaluated (see Table 2
for details). During this six-month period, participants
independently decide whether or not they continue with
an exercise program. A Past Six-Month Physical Activity
Questionnaire [33] is completed by participants to deter-
mine the amount of physical activity they engaged in
following the completion of the supervised exercise
sessions. This questionnaire permits a categorization of
participants by their activity levels to help assess the
extent to which changes in cerebrovascular and cogni-
tive function are maintained six-months following the
exercise intervention.
Blood sampling and biomarker assessments
Fasted venous blood samples are collected five times
from each participant as shown in Figure 1. Sex steroid
hormone status (estradiol, progesterone, testosterone,
sex hormone binding globulin), lipids (cholesterol, high
and low density lipoprotein, triglycerides), hematology
(complete blood count), thyroid (thyroid stimulating hor-
mone), renal (creatinine), hepatic (alanine aminotransferase
and bilirubin), and markers of vascular function influenced
by age and physical fitness [34] (i.e., oxidative and nitrative
stress, antioxidant enzyme capacity, and products of nitric
oxide metabolism) are being measured.
For participants who provide consent for genetic
testing, blood samples are also collected for this purpose.
This testing will include catechol-O-methyl-transferase,
brain-derived neurotropic factor, and apolipoprotein E
ε4 genotyping, which have previously been shown to
influence cognitive performance [35-37]. In addition,
vascular endothelial growth factor genotyping, which
can be influenced by exercise presumably via vascular-
mediated mechanisms, will also be done [38].
Maximal aerobic capacity and anthropometric
measurements
All participants undergo assessments of fitness level by a
maximal aerobic capacity (VO2max) test and anthropo-
metric measurements during each phase. Participants
are instructed to refrain from vigorous exercise the day
of testing, ingesting caffeine and/or alcohol six hours
prior to testing and eating a heavy meal four hours prior
to testing. Anthropometric measurements include height,
weight, circumference measurements (waist and hip),
body composition (bioelectrical impedance analysis), and
grip strength. The VO2max test is conducted on a
motorized treadmill and follows the Bruce protocol [39].
A plateau in oxygen uptake with increasing work rate isobserved (<2 mL/kg/min), a respiratory exchange ratio
(RER) of at least 1.15, and age-predicted maximal heart
rate (210-(age X 0.65)) are used as criteria for stopping the
test (as recommended by the Canadian Society for Exer-
cise Physiology (CSEP) [40] and American Thoracic Soci-
ety (ATS) [41]). Outcome measures for the VO2max test
include oxygen uptake, carbon dioxide production, venti-
lation (tidal volume and breathing frequency), rating of
perceived exertion (Borg scale), continuous heart rate
recordings (12-lead electrocardiogram (ECG)), and sys-
temic blood pressure.
This fitness test determines each study participant’s
maximal aerobic capacity that is used to determine work
rates for the submaximal exercise test (during the cere-
brovascular function test) and the target heart rate zones
for the exercise intervention.Cerebrovascular function
Cerebrovascular response to carbon dioxide and sub-
maximal exercise is assessed in participants who have
refrained from exercising the day of the test and eating
or drinking anything other than water, two hours prior
to testing. A capillary blood sample is taken from the
middle finger and immediately analyzed for PO2 and
PCO2, acid/base status, glucose, hematocrit, potassium,
sodium, chloride, and calcium levels (Radiometer ABL
800, Denmark). Participants sit quietly in a chair while
they are fitted with monitoring equipment. In order to
noninvasively measure the CBF of the middle cerebral ar-
tery (MCA), a 2-MHz transcranial Doppler ultrasound
(TCD) is used (Toc Neurovision™, Multigon Industries,
Inc., Yonkers, NY) [42]. To locate the MCA, the TCD
probe is placed in the temporal region just above the end
of the zygomatic process close to the ear, using techniques
previously described [42]. Maximum peak velocity ( VP ),
intensity-weighted mean ( VIWM ), an index of the cross-
sectional area of the vessel called power (P), cerebrovascu-
lar conductance, and cerebrovascular reserve are recorded
as previously described [12]. Outcome measures for this
test include continuous TCD recordings, heart rate (3-lead
ECG; Micromon 7142 B, Kontron Medical, Milton
Keynes, UK), blood pressure (beat-by-beat using finger
pulse photoplethysmography, Finometer, Finapres Medical
Systems, Amsterdam, The Netherlands), and arterial
hemoglobin saturation (finger pulse oximetry; 3900p,
Datex-Ohmeda, Madison, WI, USA).
We have previously developed and tested the protocol
for this test [12]. In short, baseline end-tidal respiratory
measures (PCO2 and PO2) are recorded using dedicated
software (Chamber, University Laboratory of Physiology,
Oxford, UK), during a 10-minute baseline period. With
their nose occluded, each participant breathes through a
mouthpiece connected to a fine capillary that is connected
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Denmark) in which end-tidal respiratory measures (PCO2
and PO2) are analyzed. These end-tidal gases are averaged
over the 10 minutes, and are used to determine the
desired end-tidal pressure carbon dioxide (PETCO2) and
end-tidal pressure oxygen (PETO2) for cerebrovascular
response to an euoxic hypercapnia test. Control of desired
PETCO2 and PETO2 values is achieved accurately and
continuously using sophisticated software (BreatheM
v2.40, University Laboratory of Physiology, Oxford, UK)
and dynamic end-tidal forcing technique as previously
described [43,44]. The test lasts 17 minutes with two
3-minute steps of carbon dioxide. For the first minute,
participants breathe room air only. This time period is
followed by a five-minute baseline period in which the
PETCO2 is held at +1.0 mmHg above the participants’Table 3 BIM neuropsychological assessment
Domain Test Descript
Attention Attention Network Test [51-53] Compute
altering,
Auditory Consonant Trigram Test [54] Auditory
followed
several se
Processing Speed Symbol-Digit Modalities [55] Simple su
Both writ
























North American Adult Reading Test [60] 61 differe
Canadian
Mood Profile of Mood States [46,61] 65 adject
the respo
dejection
Sleep Pittsburg Sleep Quality Index [47] Self-repo
Epworth Sleepiness Scale [48] Self-repo




Cognitive Activity Lifetime Cognitive Questionnaire




(all test sessions) [62]
23 quest
their liveresting PETCO2 value. Following baseline, PETCO2 is
increased to +5.0 mmHg above normal resting values and
held for three minutes and then is increased to +8.0 mmHg
and is again held for three minutes. Lastly, PETCO2 is
dropped back down to +1.0 mmHg above resting values
and held for the final five minutes of the test.
Following the hypercapnia test, participants rest for
20–30 minutes. Then, participants are seated on the re-
cumbent cycle ergometer and cerebrovascular response to
submaximal exercise is assessed. This test lasts 30 minutes
during which participants complete two six-minute inter-
vals of exercise as previously described [12].
Assessment of cognition, mood, sleep, and social support
Participants undergo cognitive testing four times, at six
month intervals, during the course of the study (seeion
rized test of the efficiency of 3 attention networks, including tests of
orienting and executive control (flanker test)
presentation of 3 consonant trigrams (i.e., three single consonant letters)
by a number. The subject is instructed to subtract from that number for
conds until cued, and then asked to recall the letters
bstitution task pairing specific numbers with given geometric figures.
ten (90 seconds) and oral (90 seconds) forms administered
ry Test (List learning of 12 words rehearsed for six trials)
ecall
le Choice recognition
layed recall of 12 words (30 minutes following multiple choice)
visual memory in which the subject is asked to copy the figure and
s it from memory at an immediate test and at a 30 minute delay
orting Test- one card set is randomly assigned to each session (i.e., one
per phase) in which the free-sorting and recognition conditions are
ord Interference Test- four conditions are presented to participants
ur naming, word reading, inhibition, and inhibition/switching) and
ts must follow the presented rule to orally complete the task as
y as possible
Fluency Test- participants must say as many words as possible in
ds for each condition (i.e., letter fluency, category fluency, and category
)
nt rare words are presented with scoring based on American and
punctuation rules
ives are presented that are rated by subjects using a 5-point scale. From
nses 6 factors are derived (tension-anxiety, vigour-activity, depression-
, fatigue-inertia, anger-hostility, and confusion-bewilderment
rt questionnaire of the last month sleep habits/sleep quality
rt of general daytime sleepiness
rt questionnaire of perceived social support from family, friends, and
dy participants
ions that assess cognitive activities participants were engaged in during
d (age 6), teens (age 12), young adults (age 18), and adulthood (age 40)
ions that assess the degree to which participants are cognitively active in
s at the present time
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experimental tests done). The tests were chosen to as-
sess cognitive domains that had previously been shown
to be affected by fitness training, with a special focus on
executive functions, processing speed, and memory
[21,27,45]. In addition, we will look for changes in mood
[46] and sleep [47,48] using validated self-report ques-
tionnaires. Involvement in the study might modify the
perception by participants of their observed social sup-
port (i.e., the feeling that one is care for, has assistance
available from other people, and that one is part of a
supportive social network). As higher levels of perceived
social support could increase adherence to the exercise
program and have an independent beneficial impact on
both mental and physical health (see [49] for review and
discussion), perceived social support will be measured
during the course of the study by a modified version of
the Lubben Social Network Scale [50]. The testing
sessions lasts approximately 120 minutes with short
breaks taken as necessary. The same testing order is
maintained through all assessments during the study.
Questionnaires
Physical activity questionnaires
At Pre-intervention Phase Test 1B participants complete
the interviewer-administered Lifetime Physical Activity
Questionnaire to quantify lifetime occupational, house-
hold, and exercise/sports activities and used to deter-
mine lifetime physical activity patterns [31]. The Past
Year Physical Activity Questionnaire [33] is self-reported
and given to participants immediately following the
completion of the exercise intervention, which assesses
physical activities while enrolled in the BIM study. At
the completion of the study (Post-intervention Phase 3),
participants are given the Past Six Month Physical Activity
Questionnaire to assess their activity level six-months
following completion of the exercise intervention.
Diet history questionnaire
The Diet History Questionnaire (DHQ) is a self-
administered food frequency questionnaire originally
designed by the National Cancer Institute but modified
for use in Canada [30]. Consisting of 146 questions about
124 different food items, the questionnaire includes
questions about portion size, seasonal intake, and fat usage
within the past 12 months [30]. Participants complete the
questionnaire at enrollment into the study and following
the completion of the exercise intervention.
Statistical analysis
The primary outcome measure is the change in overall
cognitive function (defined as the average of standardized
cognitive domain scores) over time. The sample size
estimates assume a two-tailed alpha level of 0.05, power of90% (β = 0.1) and a change in overall cognitive score of 0.2
standard deviation units based on Brown et al. [12]. To
account for a predicted 15% dropout rate to account for
withdrawals [63] and non-compliance with the exercise
sessions (i.e., attendance 85% or less of all sessions), we
will recruit 125 men and 125 women (n = 250). The pri-
mary outcome analysis within individuals will use repeated
measures analysis of variance using a general linear mixed
model. Cardiorespiratory fitness, vascular measurements
of resting CBF, cerebrovascular reserve, cerebrovascular
conductance, mood and sleep are secondary outcome
measures. The covariates being considered in our analysis
include age, sex, education, socio-economic status, BMI,
hormones, lipids profiles, genetics, diet, physical activity
and physical fitness (i.e. VO2max). Multivariable methods
will be used to determine if covariates are predictors of
our primary outcome measure (overall cognition) [12].
Discussion
Current projections suggest that by 2031, approximately
25% of the Canadian population will be over the age of
65 [7] and in 2050, the estimated world population over
the age of 60 will be 2 billion [3]. With societal aging, a
progressive increase in the absolute number of in-
dividuals suffering from age-associated health issues like
cerebrovascular disease, VaD, and AD will inevitably
occur unless we can change the likelihood of these
events occurring. If we cannot, population aging will
lead to a significantly greater burden on the health and
social care system of our country and around the world.
Effective prevention of these diseases is of paramount
importance. A promising approach is encouraging higher
levels of physical activity since exercise may delay or
prevent the progression of cognitive decline associated
with aging, prevent cerebrovascular disease, and delay the
onset of AD and related dementias [64].
The BIM study is designed to add to the literature on
whether exercise can be an effective means of decreasing
the effects of aging on cognition. This study will combine
detailed physiological and cognitive data with socio-
demographic, biologic, and lifestyle information obtained
from a relatively large and well defined older population.
By performing an exercise intervention we are able to
investigate the extent to which cerebrovascular physiology
might act as a mediating factor between exercise and
cognition. If confirmed this raises the possibility of cere-
brovascular measures functioning as a surrogate marker
of brain health in future studies of exercise interventions.
The BIM study uses state-of-the-art measurements of
cerebrovascular function, physical fitness, cognitive func-
tion, lifestyle, sleep, biologic, and genetic markers all of
which strengthen the study. The Laboratory for Human
Cerebrovascular Physiology houses sophisticated equip-
ment to control end-tidal PO2 and PCO2 accurately and
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The VO2max testing protocols used in the study are
considered the “gold-standard” practice for the assess-
ment of physical fitness, thereby adding strength to the
study since we avoid problems associated with predictive
tests by measuring VO2max rather than VO2peak [65].
The comprehensive neuropsychological test battery
allows us to assess multiple aspects of cognitive func-
tion. The battery is administered at multiple time points
through the study that will allow the assessment of
whether the exercise intervention has an impact on
cognitive function, how long it takes to become evident,
and its duration. We have included numerous self-
administered questionnaires to measure changes in
dietary intake, sleep habits, physical activity levels and
cognitive abilities at differing time points. Collectively,
these data will provide insights regarding the possible
mechanisms whereby exercise improves cerebrovascular
and cognitive function.
The current study is unique because all the participants
of our study attend our supervised and structured exercise
program for six-months. Further, the exercise program is
individually tailored to each participant as exercise pres-
criptions are based on each individual’s heart rate reserve.
This supervised intervention assesses participants’ pro-
gression through the exercise program with modifications
to the intervention made as needed. The BIM study uses a
quasi-experimental prospective cohort design because it
reduces variability over time since each participant is their
own control during the repeated baseline assessment over
a six-month period. An inherent weakness is the potential
carry over or practice effects in repeated cognitive testing.
We have attempted to deal with this issue by 1) repeating
the baseline cognitive testing to observe the stability of
the performance measures over time before the interven-
tion, 2) using alternate forms of tests when possible (i.e.,
verbal fluency, selective reminding, MCG figure, card
sorting), and 3) we will analyze the cognitive data for over-
all trends at the four time points to examine for a global
practice effect over time. The next logical step in our
research program will be a randomized controlled trial in
first a healthy and then in a diseased population (e.g.
individuals with Mild Cognitive Impairment or stroke).
The mechanisms whereby exercise-induced increases
in cerebrovascular reserve improve cognitive function
are unknown. At this time, we are focused on demon-
strating the physiologic mechanisms by which exercise
confers its beneficial influence on cognition. The BIM
study is the first to examine the influence of an aerobic
exercise intervention on cerebrovascular and cognitive
function in a healthy aging population. The results from
this study may inform the development of new therapies
to reduce or prevent the cognitive decline associated
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